Literature DB >> 9566797

HIV-1 does not alter in vitro and in vivo IL-10 production by human monocytes and macrophages.

A Bergamini1, F Bolacchi, E Faggioli, R Placido, S Vendetti, L Cappannoli, L Ventura, G Cerasari, I Uccella, M Andreoni, G Rocchi.   

Abstract

The present study analyses the ability of HIV-1 to modulate IL-10 production in cells of monocyte-macrophage lineage cultured in the presence of macrophage colony-stimulating factor (M-CSF). Both monocytes and macrophages spontaneously produced low amount of IL-10. Lipopolysaccharide (LPS) induced a strong IL-10 response in fresh monocytes and in M-CSF-treated macrophages. In contrast, macrophages cultured in the absence of M-CSF exhibited a marked decrease in their susceptibility to LPS stimulation. M-CSF increased the IL-10 response of macrophages to LPS by enhancing both the expression of membrane-bound CD14, the protein that serves as LPS receptor, and the sensibility of CD14-expressing cells to LPS stimulation. Neither spontaneous nor LPS-induced expression of IL-10 was modulated in monocytes and macrophages by infection with eight monocytotropic strains, as demonstrated by ELISA and cytofluorimetric analysis. In contrast, all the HIV-1 strains primed macrophages for an increased IL-6 response to LPS stimulation. To determine whether IL-10 production was associated with in vivo infection, monocytes from AIDS individuals were analysed for IL-10 production. We found that neither spontaneous nor LPS-induced IL-10 production were different between healthy controls and HIV-infected patients. Taken together, these data strongly suggest that HIV-1 infection of monocytes-macrophages does not play a significant role in the regulation of IL-10 in infected patients. This study also emphasizes the role of M-CSF activation in the regulation of the cytokine response in macrophages.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9566797      PMCID: PMC1904934          DOI: 10.1046/j.1365-2249.1998.00563.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  46 in total

1.  Serum IL-10 levels in HIV-positive subjects: correlation with CDC stages.

Authors:  F Ameglio; P Cordiali Fei; M Solmone; C Bonifati; G Prignano; A Giglio; F Caprilli; G Gentili; M R Capobianchi
Journal:  J Biol Regul Homeost Agents       Date:  1994 Apr-Jun       Impact factor: 1.711

2.  Phase I trial of recombinant macrophage colony-stimulating factor and recombinant gamma-interferon: toxicity, monocytosis, and clinical effects.

Authors:  L M Weiner; W Li; M Holmes; R B Catalano; M Dovnarsky; K Padavic; R K Alpaugh
Journal:  Cancer Res       Date:  1994-08-01       Impact factor: 12.701

3.  Cystamine potently suppresses in vitro HIV replication in acutely and chronically infected human cells.

Authors:  A Bergamini; M Capozzi; L Ghibelli; L Dini; A Salanitro; G Milanese; T Wagner; S Beninati; C D Pesce; C Amici
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

4.  Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS.

Authors:  J Embretson; M Zupancic; J L Ribas; A Burke; P Racz; K Tenner-Racz; A T Haase
Journal:  Nature       Date:  1993-03-25       Impact factor: 49.962

5.  Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals.

Authors:  C Graziosi; G Pantaleo; K R Gantt; J P Fortin; J F Demarest; O J Cohen; R P Sékaly; A S Fauci
Journal:  Science       Date:  1994-07-08       Impact factor: 47.728

6.  Induction of interleukin-10 by human immunodeficiency virus type 1 and its gp120 protein in human monocytes/macrophages.

Authors:  P Borghi; L Fantuzzi; B Varano; S Gessani; P Puddu; L Conti; M R Capobianchi; F Ameglio; F Belardelli
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

7.  Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus.

Authors:  M Clerici; T A Wynn; J A Berzofsky; S P Blatt; C W Hendrix; A Sher; R L Coffman; G M Shearer
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

8.  Interferons as macrophage-activating factors. III. Preferential effects of interferon-gamma on the interleukin 1 secretory potential of fresh or aged human monocytes.

Authors:  F Arenzana-Seisdedos; J L Virelizier; W Fiers
Journal:  J Immunol       Date:  1985-04       Impact factor: 5.422

9.  IL-10 is induced during HIV-1 infection and is capable of decreasing viral replication in human macrophages.

Authors:  R E Akridge; L K Oyafuso; S G Reed
Journal:  J Immunol       Date:  1994-12-15       Impact factor: 5.422

10.  Th2-like CD8+ T cells showing B cell helper function and reduced cytolytic activity in human immunodeficiency virus type 1 infection.

Authors:  E Maggi; M G Giudizi; R Biagiotti; F Annunziato; R Manetti; M P Piccinni; P Parronchi; S Sampognaro; L Giannarini; G Zuccati; S Romagnani
Journal:  J Exp Med       Date:  1994-08-01       Impact factor: 14.307

View more
  2 in total

1.  Macrophage-mediated responses to Candida albicans in mice expressing the human immunodeficiency virus type 1 transgene.

Authors:  Mathieu Goupil; Emilie Bélanger Trudelle; Véronique Dugas; Catherine Racicot-Bergeron; Francine Aumont; Serge Sénéchal; Zaher Hanna; Paul Jolicoeur; Louis de Repentigny
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

2.  Expression of killer inhibitory receptors on cytotoxic cells from HIV-1-infected individuals.

Authors:  M D Galiani; E Aguado; R Tarazona; P Romero; I Molina; M Santamaria; R Solana; J Peña
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.